Newsletter

Our new pick is: IGC

Good Morning Traders,

Today's alert is something quite special and we are very excited about the upside that could be on the horizon!

This alert is not only a penny stock trading on the NYSE, but it also has a low float, and looks like it may be at the beginning of a MONSTER BOUNCE!

Our last morning announcement saw a whopping 500% move in just hours!

India Globalization Capital, Inc. (NYSE: IGC)

http://www.igcinc.us/

IGC is a penny stock trading on the NYSE. This means more exposure!

At around 35 cents, this could be our next big mover!

The company is on a mission to shake up the medical industry using legal marijuana.

Last month shares of IGC were as high as 55 cents. The stock has been descending in recent weeks and may have bottomed out on Wednesday when it hit a little over 30 cents.

Yesterday the stock closed at $0.3599!

Could this be the beginning of a big bounce?

About the Company:

IGC, Inc. is on a mission to gain a leading position in the emerging legal cannabis industry!

The company's strategy is to develop a product portfolio of phytocannabinoid-based therapies for the treatment of a wide range of therapeutic indications including pain, epilepsy, and other niche severe terminal diagnosis, which are life altering or life threatening.

Marijuana is a huge industry. Cannabis legalization is rapidly outpacing opposition and more states are allowing it for medicinal use and recreational use legally.

We are in a revolution and it's companies like IGC to pay attention to!

IGC is led by Ram Mukunda who according to the company's website, has built $1 billion in businesses in 10 countries!

The company recently applied for a provisional patent based on a novel therapy that uses extracts from the cannabis plant for the treatment of multiple seizure disorders and medical refractory epilepsy. (http://finance.yahoo.com/news/igc-files-preliminary-phytocannabinoid-patent-122000815.html)

The therapy, which is expected to also have applications in veterinarian use, is administered using a variety of delivery technologies.

IGC expects to establish metabolic profiling and apply to the FDA for trials!

Approximately 65 million people around the world have epilepsy — over 2 million in the Unites States alone.

Every year, the United States sees 150,000 new diagnoses of epilepsy.

The onset of Epilepsy can be life threatening with long-term implications including mental health problems, cognitive deficits and morphological changes.

Epilepsy also greatly affects life style, as sufferers live in fear of consequential injury or the inability to perform daily tasks.

Millions of cats and dogs are also victims too.

The scientific community has shown that phytocannabinoid extracts from the cannabis plant including Cannabidiol (CBD), Tetrahydrocannabinol (THC), and others have anti-convulsive properties in humans.

Any developments from the FDA on trials could send IGC shares soaring so keep an eye on the company's news!

GW Pharmaceuticals (GWPH) which trades at $120 a share, has already commenced clinical trials to test Epidiolex, comprising mostly of CBD.

IGC at these penny stock levels could represent massive opportunity right now!

Hurry and start your research. This could be our next potential TRIPLE DIGIT MOVER!

We are issuing a VERY STRONG alert on IGC right now!

GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ThePennyStockCrew.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by ThePennyStockCrew.com or an offer or solicitation to buy or sell any security. Neither the owner of ThePennyStockCrew.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit ThePennyStockCrew.com. ThePennyStockCrew.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. Penny Stock Crew has not been compensated for this email.

Questions regarding this release may be sent to info@ThePennyStockCrew.com Notice of Stock Price Movements and Volatility Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week. Some of the content in this release contains forward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and the Financial Industry Regulatory Authority ("FINRA") website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. ThePennyStockCrew.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and ThePennyStockCrew.com Network has no obligation to update any of the information provided. ThePennyStockCrew.com its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. ThePennyStockCrew.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. ThePennyStockCrew.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does ThePennyStockCrew.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that ThePennyStockCrew.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that ThePennyStockCrew.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. ThePennyStockCrew.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold ThePennyStockCrew.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. ThePennyStockCrew.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm. ThePennyStockCrew.com has not been compensated for this email.

This message was sent to xxxxxx@gmail.com from:

Penny Stock Crew, info@thepennystockcrew.com, Penny Stock Crew | 433 Plaza Real, Suite 275 | Boca Raton , FL 33432